Ochratoxin a and mitotic disruption: Mode of action analysis of renal tumor formation by ochratoxin A

Toxicological Sciences

Volumn 127, Issue 2, 2012, Pages 315-330

  Mally, Angela ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Carcinogenesis; Mitosis; MoA; Ochratoxin A

Indexed keywords

CARCINOGEN; DNA; OCHRATOXIN;

CARCINOGEN DNA INTERACTION; CARCINOGENESIS; CARCINOGENICITY; DATA BASE; DOSE RESPONSE; FOOD SAFETY; KIDNEY CANCER; KIDNEY TUBULE ABSORPTION; MITOSIS; REVIEW;

RODENTIA;

EID: 84861476300     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs105     Document Type: Review

References (155)

1. Adler, M., Muller, K., Rached, E., Dekant, W., and Mally, A. (2009). Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 30, 711-719.
2. Akhtar, A., and Becker, P. B. (2000). Activation of transcription through histone H4 acetylation by MOF, an acetyltransferase essential for dosage compensation in Drosophila. Mol. Cell 5, 367-375.
3. Anzai, N., Jutabha, P., Enomoto, A., Yokoyama, H., Nonoguchi, H., Hirata, T., Shiraya, K., He, X., Cha, S. H., Takeda, M., et al. (2005). Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules. J. Pharmacol. Exp. Ther. 315, 534-544.
4. Anzai, N., Jutabha, P., and Endou, H. (2010). Molecular mechanism of ochratoxin A transport in the kidney. Toxins (Basel) 2, 1381-1398.
5. Aoudia, N., Callu, P., Grosjean, F., and Larondelle, Y. (2009). Effectiveness of mycotoxin sequestration activity of micronized wheat fibres on distributionof ochratoxin A in plasma, liver and kidney of piglets fed a naturally contaminated diet. Food Chem. Toxicol. 47, 1485-1489.
6. Arbillaga, L., Azqueta, A., Ezpeleta, O., and Lopez de Cerain, A. (2007). Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: Evidence of the relationship with cytotoxicity. Mutagenesis 22, 35-42.
7. Arbillaga, L., Vettorazzi, A., Gil, A. G., Joost, H. M., van Delft, J. H., Garcia-Jalon, J. A., and Lopez de Cerain, A. (2008). Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration. Toxicol. Appl. Pharmacol. 230, 197-207.
8. Avvakumov, N., and Cote, J. (2007). The MYST family of histone acetyltransferases and their intimate links to cancer. Oncogene 26, 5395-5407.
9. Bartsch, H., Malaveille, C., Camus, A. M., Martel-Planche, G., Brun, G., Hautefeuille, A., Sabadie, N., Barbin, A., Kuroki, T., Drevon, C., et al. (1980). Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems. Mutat. Res. 76, 1-50.
10. Beckouet, F., Hu, B., Roig, M. B., Sutani, T., Komata, M., Uluocak, P., Katis, V. L., Shirahige, K., and Nasmyth, K. (2010). An Smc3 acetylation cycle is essential for establishment of sister chromatid cohesion. Mol. Cell 39, 689-699.
11. Bendele, A. M., Carlton, W. W., Krogh, P., and Lillehoj, E. B. (1985a). Ochratoxin A carcinogenesis in the (C57BL/6J X C3H)F1 mouse. J. Natl. Cancer Inst. 75, 733-742.
12. Bendele, A. M., Neal, S. B., Oberly, T. J., Thompson, C. Z., Bewsey, B. J., Hill, L. E., Rexroat, M. A., Carlton, W. W., and Probst, G. S. (1985b). Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assays. Food Chem. Toxicol. 23, 911-918.
13. Boesch-Saadatmandi, C., Wagner, A. E., Graeser, A. C., Hundhausen, C., Wolffram, S., and Rimbach, G. (2009). Ochratoxin A impairs Nrf2-dependent gene expression in porcine kidney tubulus cells. J. Anim. Physiol. Anim. Nutr. (Berl) 93, 547-554.
14. Bolden, J. E., Peart, M. J., and Johnstone, R. W. (2006). Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5, 769-784.
15. Boobis, A. R., Cohen, S. M., Dellarco, V., McGregor, D., Meek, M. E., Vickers, C., Willcocks, D., and Farland, W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36, 781-792.
16. Boorman, G. A., McDonald, M. R., Imoto, S., and Persing, R. (1992). Renal lesions induced by ochratoxin A exposure in the F344 rat. Toxicol. Pathol. 20, 236-245.
17. Boveri, T. (1929). The Origin of Malignant Tumors. Waverly Press, Baltimore, MD.
18. Brooks, C. L., and Gu, W. (2011). The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2, 456-462.
19. Brown, A. L., Odell, E. W., and Mantle, P. G. (2007). DNA ploidy distribution in renal tumours induced in male rats by dietary ochratoxin A. Exp. Toxicol. Pathol. 59, 85-95.
20. Bu, P., Evrard, Y. A., Lozano, G., and Dent, S. Y. (2007). Loss of Gcn5 acetyltransferase activity leads to neural tube closure defects and exencephaly in mouse embryos. Mol. Cell. Biol. 27, 3405-3416.
21. Buist, S. C., and Klaassen, C. D. (2004). Rat and mouse differences in genderpredominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab. Dispos. 32, 620-625.
22. Castedo, M., Perfettini, J. L., Roumier, T., Andreau, K., Medema, R., and Kroemer, G. (2004). Cell death by mitotic catastrophe: A molecular definition. Oncogene 23, 2825-2837.
23. Castegnaro, M., Bartsch, H., Bereziat, J. C., Arvela, P., Michelon, J., and Broussolle, L. (1989). Polymorphic ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolizers of debrisoquine. Xenobiotica 19, 225-230.
24. Castegnaro, M., Mohr, U., Pfohl-Leszkowicz, A., Esteve, J., Steinmann, J., Tillmann, T., Michelon, J., and Bartsch, H. (1998). Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 77, 70-75.
25. Cavin, C., Delatour, T., Marin-Kuan, M., Fenaille, F., Holzhauser, D., Guignard, G., Bezencon, C., Piguet, D., Parisod, V., Richoz-Payot, J., et al. (2009). Ochratoxin A-mediated DNA and protein damage: Roles of nitrosative and oxidative stresses. Toxicol. Sci. 110, 84-94.
26. Cavin, C., Delatour, T., Marin-Kuan, M., Holzhauser, D., Higgins, L., Bezencon, C., Guignard, G., Junod, S., Richoz-Payot, J., Gremaud, E., et al. (2007). Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol. Sci. 96, 30-39.
27. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., and Mann, M. (2009). Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840.
28. Corcuera, L. A., Ibanez-Vea, M., Vettorazzi, A., Gonzalez-Penas, E., and Cerain, A. L. (2011). Validation of a UHPLC-FLD analytical method for the simultaneous quantification of aflatoxin B1 and ochratoxin A in rat plasma, liver and kidney. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879, 2733-2740.
29. Cosimi, S., Orta, L., Mateos, S., and Cortes, F. (2009). The mycotoxin ochratoxin A inhibits DNA topoisomerase II and induces polyploidy in cultured CHO cells. Toxicol. In Vitro 23, 1110-1115.
30. Czakai, K., Müller, K., Mosesso, P., Pepe, G., Schulze, M., Gohla, A., Patnaik, D., Dekant, W., Higgins, J. M., and Mally, A. (2011). Perturbation of mitosis through inhibition of histone acetyltransferases: The key to ochratoxin A toxicity and carcinogenicity? Toxicol. Sci. 122, 317-329.
31. Dahlmann, A., Dantzler, W. H., Silbernagl, S., and Gekle, M. (1998). Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: The nephrotoxin can be reabsorbed in all nephron segments by different mechanisms. J. Pharmacol. Exp. Ther. 286, 157-162.
32. Degen, G. H., Gerber, M. M., Obrecht-Pflumio, S., and Dirheimer, G. (1997). Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures. Arch. Toxicol. 71, 365-371.
33. Dekker, F. J., and Haisma, H. J. (2009). Histone acetyl transferases as emerging drug targets. Drug Discov. Today 14, 942-948.
34. Delatour, T., Mally, A., Richoz, J., Ozden, S., Dekant, W., Ihmels, H., Otto, D., Gasparutto, D., Marin-Kuan, M., Schilter, B., et al. (2008). Absence of 2'-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS. Mol. Nutr. Food Res. 52, 472-482.
35. Domijan, A. M., Peraica, M., Ferencic, Z., Cuzic, S., Fuchs, R., Lucic, A., and Radic, B. (2004). Ochratoxin A-induced apoptosis in rat kidney tissue. Arh Hig Rad Toksikol 55, 243-248.
36. Domijan, A. M., Zeljezic, D., Kopjar, N., and Peraica, M. (2006). Standard and Fpg-modified comet assay in kidney cells of ochratoxin A- and fumonisin B(1)-treated rats. Toxicology 222, 53-59.
37. Dopp, E., Muller, J., Hahnel, C., and Schiffmann, D. (1999). Induction of genotoxic effects and modulation of the intracellular calcium level in syrian hamster embryo (SHE) fibroblasts caused by ochratoxin A. Food Chem. Toxicol. 37, 713-721.
38. Dwivedi, P., and Burns, R. B. (1985). Immunosuppressive effects of ochratoxin A in young turkeys. Avian Pathol. 14, 213-225.
39. European Food Safety Authority (EFSA). (2006). Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food, EFSA-Q-2005-154. EFSA J. 365, 1-56.
40. Ehrlich, V., Darroudi, F., Uhl, M., Steinkellner, H., Gann, M., Majer, B. J., Eisenbauer, M., and Knasmuller, S. (2002). Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells. Food Chem. Toxicol. 40, 1085-1090.
41. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Castegnaro, M., and Manderville, R. A. (2004). Evidence for covalent DNA adduction byochratoxin A following chronic exposure to rat and subacute exposure to pig. Chem. Res. Toxicol. 17, 1289-1296.
42. Follmann, W., Hillebrand, I. E., Creppy, E. E., and Bolt, H. M. (1995). Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha. Arch. Toxicol. 69, 280-286.
43. Follmann, W., and Lucas, S. (2003). Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system. Arch. Toxicol. 77, 298-304.
44. Galtier, P., Charpenteau, J. L., Alvinerie, M., and Labouche, C. (1979). The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration. Drug Metab. Dispos. 7, 429-434.
45. Ganem, N. J., Storchova, Z., and Pellman, D. (2007). Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 17, 157-162.
46. Gautier, J., Richoz, J., Welti, D. H., Markovic, J., Gremaud, E., Guengerich, F. P., and Turesky, R. J. (2001a). Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes. Chem. Res. Toxicol. 14, 34-45.
47. Gautier, J. C., Holzhaeuser, D., Markovic, J., Gremaud, E., Schilter, B., and Turesky, R. J. (2001b). Oxidative damage and stress response from ochratoxin A exposure in rats. Free Radic. Biol. Med. 30, 1089-1098.
48. Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S. F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000). Mutations truncating the EP300 acetylase in human cancers. Nat. Genet. 24, 300-303.
49. Gekle, M., Schwerdt, G., Freudinger, R., Mildenberger, S., Wilflingseder, D., Pollack, V., Dander, M., and Schramek, H. (2000). Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J. Pharmacol. Exp. Ther. 293, 837-844.
50. Gennari, A., Pazos, P., Boveri, M., Callaghan, R., Casado, J., Maurici, D., Corsini, E., and Prieto, P. (2004). New insights into the mechanisms involved in renal proximal tubular damage induced in vitro by ochratoxin A. J. Biochem. Mol. Toxicol. 18, 43-49.
51. Gillman, I. G., Clark, T. N., and Manderville, R. A. (1999). Oxidation of ochratoxin A by an Fe-porphyrin system: Model for enzymatic activation and DNA cleavage. Chem. Res. Toxicol. 12, 1066-1076.
52. Gotoh, Y., Kato, Y., Stieger, B., Meier, P. J., and Sugiyama, Y. (2002). Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. Am. J. Physiol. Endocrinol. Metab. 282, E1245-E1254.
53. Gross-Steinmeyer, K., Weymann, J., Hege, H. G., and Metzler, M. (2002). Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes. J. Agric. Food Chem. 50, 938-945.
54. Grosse, Y., Baudrimont, I., Castegnaro, M., Betbeder, A. M., Creppy, E. E., Dirheimer, G., and Pfohl-Leszkowicz, A. (1995). Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells. Chem. Biol. Interact. 95, 175-187.
55. Ha, G. H., Kim, H. S., Lee, C. G., Park, H. Y., Kim, E. J., Shin, H. J., Lee, J. C., Lee, K. W., and Lee, C. W. (2009). Mitotic catastrophe is the predominant response to histone acetyltransferase depletion. Cell Death Differ. 16, 483-497.
56. Hagelberg, S., Hult, K., and Fuchs, R. (1989). Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. J. Appl. Toxicol. 9, 91-96.
57. Harwig, J., Kuiper-Goodman, T., and Scott, P. M. (1983). Microbial food toxicants: Ochratoxins. In Handbook of Foodborne Diseases of Biological Origin (M. Rechcigl, Ed.) pp. 193-238. CRC Press, Boca Raton, FL.
58. Haubeck, H. D., Lorkowski, G., Kolsch, E., and Roschenthaler, R. (1981). Immunosuppression by ochratoxin A and its prevention by phenylalanine. Appl. Environ. Microbiol. 41, 1040-1042.
59. Hibi, D., Suzuki, Y., Ishii, Y., Jin, M., Watanabe, M., Sugita-Konishi, Y., Yanai, T., Nohmi, T., Nishikawa, A., and Umemura, T. (2011). Site-specific in vivo mutagenicity in the kidney of gpt delta rats given a carcinogenic dose of ochratoxin A. Toxicol. Sci. 122, 406-414.
60. Hoffmann, D., Fuchs, T. C., Henzler, T., Matheis, K. A., Herget, T., Dekant, W., Hewitt, P., and Mally, A. (2010). Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity. Toxicology 277, 49-58.
61. Holmberg, T., Thuvander, A., and Hult, K. (1988). Ochratoxin A as a suppressor of mitogen-induced blastogenesis of porcine blood lymphocytes. Acta. Vet. Scand. 29, 219-223.
62. Horvath, A., Upham, B. L., Ganev, V., and Trosko, J. E. (2002). Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Toxicon 40, 273-282.
63. Ikura, T., Ogryzko, V. V., Grigoriev, M., Groisman, R., Wang, J., Horikoshi, M., Scully, R., Qin, J., and Nakatani, Y. (2000). Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102, 463-473.
64. Iyer, N. G., Ozdag, H., and Caldas, C. (2004). p300/CBP and cancer. Oncogene 23, 4225-4231.
65. Kamp, H. G., Eisenbrand, G., Janzowski, C., Kiossev, J., Latendresse, J. R., Schlatter, J., and Turesky, R. J. (2005a). Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats. Mol. Nutr. Food Res. 49, 1160-1167.
66. Kamp, H. G., Eisenbrand, G., Schlatter, J., Wurth, K., and Janzowski, C. (2005b). Ochratoxin A: Induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology 206, 413-425.
67. Kanisawa, M. (1984). Synergistic effect of citrinin on hepatorenal carcinogenesis of OA in mice. In Toxigenic Fungi - Their Toxins and Health Hazard (H. Kurata and Y. Ueno, Eds.) pp. 245-254. Elsevier, Tokyo, Japan.
68. Kato, Y., Kuge, K., Kusuhara, H., Meier, P. J., and Sugiyama, Y. (2002). Gender difference in the urinary excretion of organic anions in rats. J. Pharmacol. Exp. Ther. 302, 483-489.
69. Kikuchi, H., Kuribayashi, F., Kiwaki, N., Takami, Y., and Nakayama, T. (2011). GCN5 regulates the superoxide-generating system in leukocytes via controlling gp91-phox gene expression. J. Immunol. 186, 3015-3022.
70. King, R. W. (2008). When 2+2=5: The origins and fates of aneuploid and tetraploid cells. Biochim. Biophys. Acta 1786, 4-14.
71. Kuczuk, M. H., Benson, P. M., Heath, H., and Hayes, A. W. (1978). Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae. Mutat. Res. 53, 11-20.
72. Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L. E., Sieff, C. A., Livingston, D. M., and Yao, T. P. (2000). Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 14, 272-277.
73. Lebrun, S., and Follmann, W. (2002). Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay). Arch. Toxicol. 75, 734-741.
74. Li, X., Corsa, C. A., Pan, P. W., Wu, L., Ferguson, D., Yu, X., Min, J., and Dou, Y. (2010). MOF and H4 K16 acetylation play important roles in DNA damage repair by modulating recruitment of DNA damage repair protein Mdc1. Mol. Cell. Biol. 30, 5335-5347.
75. Ljubojevic, M., Balen, D., Breljak, D., Kusan, M., Anzai, N., Bahn, A., Burckhardt, G., and Sabolic, I. (2007). Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones. Am. J. Physiol. Renal. Physiol. 292, F361-F372.
76. Lock, E. A., and Hard, G. C. (2004). Chemically induced renal tubule tumors in the laboratory rat and mouse: Review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit. Rev. Toxicol. 34, 211-299.
77. Ljubojevic, M., Herak-Kramberger, C. M., Hagos, Y., Bahn, A., Endou, H., Burckhardt, G., and Sabolic, I. (2004). Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am. J. Physiol. Renal. Physiol. 287, F124-F138.
78. Lu, H., and Klaassen, C. (2006). Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents. Peptides 27, 850-857.
79. Lu, R., Kanai, N., Bao, Y., Wolkoff, A. W., and Schuster, V. L. (1996). Regulation of renal oatp mRNA expression by testosterone. Am. J. Physiol. 270, F332-F337.
80. Luhe, A., Hildebrand, H., Bach, U., Dingermann, T., and Ahr, H. J. (2003). A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: Expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci. 73, 315-328.
81. Maaroufi, K., Zakhama, A., Baudrimont, I., Achour, A., Abid, S., Ellouz, F., Dhouib, S., Creppy, E. E., and Bacha, H. (1999). Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Hum. Exp. Toxicol. 18, 410-415.
82. Madsen, A., Mortensen, H. P., and Hald, B. (1982). Feeding experiments with ochratoxin A contaminated barley for bacon pigs. I. Influence on pig performance and residues. Acta Agric. Scand. 33, 171-175.
83. Mally, A., Pepe, G., Ravoori, S., Fiore, M., Gupta, R. C., Dekant, W., and Mosesso, P. (2005a). Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 18, 1253-1261.
84. Mally, A., Volkel, W., Amberg, A., Kurz, M., Wanek, P., Eder, E., Hard, G., and Dekant, W. (2005b). Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats. Chem. Res. Toxicol. 18, 1242-1252.
85. Mally, A., Zepnik, H., Wanek, P., Eder, E., Dingley, K., Ihmels, H., Volkel, W., and Dekant, W. (2004). Ochratoxin A: Lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 17, 234-242.
86. Marin-Kuan, M., Cavin, C., Delatour, T., and Schilter, B. (2008). Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms. Toxicon 52, 195-202.
87. Marin-Kuan, M., Nestler, S., Verguet, C., Bezencon, C., Piguet, D., Mansourian, R., Holzwarth, J., Grigorov, M., Delatour, T., Mantle, P., et al. (2006). A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol. Sci. 89, 120-134.
88. Mateo, F., Vidal-Laliena, M., Canela, N., Busino, L., Martinez-Balbas, M. A., Pagano, M., Agell, N., and Bachs, O. (2009). Degradation of cyclin A is regulated by acetylation. Oncogene 28, 2654-2666.
89. Mayura, K., Edwards, J. F., Maull, E. A., and Phillips, T. D. (1989). The effects of ochratoxin A on postimplantation rat embryos in culture. Arch. Environ. Contam. Toxicol. 18, 411-415.
90. Mayura, K., Reddy, R. V., Hayes, A. W., and Berndt, W. O. (1982). Embryocidal, fetotoxic and teratogenic effects of ochratoxin A in rats. Toxicology 25, 175-185.
91. Miller, R. W., and Rubinstein, J. H. (1995). Tumors in Rubinstein-Taybi syndrome. Am. J. Med. Genet. 56, 112-115.
92. Mistry, P., Deacon, K., Mistry, S., Blank, J., and Patel, R. (2004). NF-kappaB promotes survival during mitotic cell cycle arrest. J. Biol. Chem. 279, 1482-1490.
93. Mosesso, P., Cinelli, S., Pinero, J., Bellacima, R., and Pepe, G. (2008). In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity. Chem. Res. Toxicol. 21, 1235-1243.
94. Munro, I. C., Moodie, C. A., Kuiper-Goodman, T., Scott, P. M., and Grice, H. C. (1974). Toxicologic changes in rats fed graded dietary levels of ochratoxin A. Toxicol. Appl. Pharmacol. 28, 180-188.
95. Nohmi, T., and Masumura, K. (2005). Molecular nature of intrachromosomal deletions and base substitutions induced by environmental mutagens. Environ. Mol. Mutagen. 45, 150-161.
96. National Toxicology Program (NTP). (1989). Toxicology and carcinogenesis studies of ochratoxin A (CAS No. 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 358, 1-142.
97. Obrecht-Pflumio, S., Grosse, Y., Pfohl-Leszkowicz, A., and Dirheimer, G. (1996). Protection by indomethacin and aspirin against genotoxicity of ochratoxin A, particularly in the urinary bladder and kidney. Arch. Toxicol. 70, 244-248.
98. O'Brien, E., Heussner, A. H., and Dietrich, D. R. (2001). Species-, sex-, and cell type-specific effects of ochratoxin A and B. Toxicol. Sci. 63, 256-264.
99. Otteneder, M., and Lutz, W. K. (1999). Correlation of DNA adduct levels with tumor incidence: Carcinogenic potency of DNA adducts. Mutat. Res. 424, 237-247.
100. Palma, N., Cinelli, S., Sapora, O., Wilson, S. H., and Dogliotti, E. (2007). Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. Chem. Res. Toxicol. 20, 1031-1037.
101. Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011). Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471, 189-195.
102. Patel, J., Pathak, R. R., and Mujtaba, S. (2011). The biology of lysine acetylation integrates transcriptional programming and metabolism. Nutr. Metab. (Lond.) 8, 12.
103. Patil, R. D., Dwivedi, P., and Sharma, A. K. (2006). Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats. Reprod. Toxicol. 22, 679-687.
104. Petkova-Bocharova, T., Stoichev, I. I., Chernozemsky, I. N., Castegnaro, M., and Pfohl-Leszkowicz, A. (1998). Formation of DNA adducts in tissues of mouse progeny through transplacental contamination and/or lactation after administration of a single dose of ochratoxin A to the pregnant mother. Environ. Mol. Mutagen. 32, 155-162.
105. Petrij, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C., Masuno, M., Tommerup, N., van Ommen, G. J., Goodman, R. H., et al. (1995). Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351.
106. Petrik, J., Zanic-Grubisic, T., Barisic, K., Pepeljnjak, S., Radic, B., Ferencic, Z., and Cepelak, I. (2003). Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch. Toxicol. 77, 685-693.
107. Pfohl-Leszkowicz, A., Chakor, K., Creppy, E. E., and Dirheimer, G. (1991). DNA adduct formation in mice treated with ochratoxin A. IARC Sci. Publ. 115, 245-253.
108. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Creppy, E. E., and Dirheimer, G. (1993). Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A. Mutat. Res. 289, 265-273.
109. Rached, E., Hard, G. C., Blumbach, K., Weber, K., Draheim, R., Lutz, W. K., Ozden, S., Steger, U., Dekant, W., and Mally, A. (2007). Ochratoxin A: 13-week oral toxicity and cell proliferation in male F344/N rats. Toxicol. Sci. 97, 288-298.
110. Rached, E., Hoffmann, D., Blumbach, K., Weber, K., Dekant, W., and Mally, A. (2008). Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin A in vivo and in vitro. Toxicol. Sci. 103, 371-381.
111. Rached, E., Pfeiffer, E., Dekant, W., and Mally, A. (2006). Ochratoxin A: Apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics? Toxicol. Sci. 92, 78-86.
112. Rasonyi, T., Schlatter, J., and Dietrich, D. R. (1999). The role of alpha2uglobulin in ochratoxin A induced renal toxicity and tumors in F344 rats. Toxicol. Lett. 104, 83-92.
113. Roninson, I. B. (2002). Oncogenic functions of tumour suppressor p21(Waf1/ Cip1/Sdi1): Association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 179, 1-14.
114. Sakuraba, K., Yokomizo, K., Shirahata, A., Goto, T., Saito, M., Ishibashi, K., Kigawa, G., Nemoto, H., and Hibi, K. (2011). TIP60 as a potential marker for the malignancy of gastric cancer. Anticancer Res. 31, 77-79.
115. Sauvant, C., Holzinger, H., and Gekle, M. (2005). Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2. J. Pharmacol. Exp. Ther. 313, 234-241.
116. Schaaf, G. J., Nijmeijer, S. M., Maas, R. F., Roestenberg, P., de Groene, E. M., and Fink-Gremmels, J. (2002). The role of oxidative stress in the ochratoxin Amediated toxicity in proximal tubular cells. Biochim. Biophys. Acta 1588, 149-158.
117. Schlatter, C., Studer-Rohr, J., and Rasonyi, T. (1996). Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit. Contam. 13(Suppl.), 43-44.
118. Schwerdt, G., Freudinger, R., Mildenberger, S., Silbernagl, S., and Gekle, M. (1999). The nephrotoxin ochratoxin A induces apoptosis in cultured human proximal tubule cells. Cell. Biol. Toxicol. 15, 405-415.
119. Schwerdt, G., Holzinger, H., Sauvant, C., Konigs, M., Humpf, H. U., and Gekle, M. (2007). Long-term effects of ochratoxin A on fibrosis and cell death in human proximal tubule or fibroblast cells in primary culture. Toxicology 232, 57-67.
120. Scibelli, A., Tafuri, S., Ferrante, M. C., Alimenti, E., Naso, B., Lucisano, A., Staiano, N., and Della Morte, R. (2003). Ochratoxin A affects COS cell adhesion and signaling. Toxicol. Appl. Pharmacol. 192, 222-230.
121. Seegers, J. C., Bohmer, L. H., Kruger, M. C., Lottering, M. L., and de Kock, M. (1994). A comparative study of ochratoxin A-induced apoptosis in hamster kidney and HeLa cells. Toxicol. Appl. Pharmacol. 129, 1-11.
122. Shahbazian, M. D., and Grunstein, M. (2007). Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75-100.
123. Sharma, R. P. (1993). Immunotoxicity of mycotoxins. J. Dairy Sci. 76, 892-897.
124. Shogren-Knaak, M., Ishii, H., Sun, J. M., Pazin, M. J., Davie, J. R., and Peterson, C. L. (2006). Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311, 844-847.
125. Singh, G. S., Chauhan, H. V., Jha, G. J., and Singh, K. K. (1990). Immunosuppression due to chronic ochratoxicosis in broiler chicks. J. Comp. Pathol. 103, 399-410.
126. Smith, A. G., and Francis, J. E. (1983). Evidence for the active renal secretion of S-pentachlorophenyl-N-acetyl-L-cysteine by female rats. Biochem. Pharmacol. 32, 3797-3801.
127. Soutoglou, E., Katrakili, N., and Talianidis, I. (2000). Acetylation regulates transcription factor activity at multiple levels. Mol. Cell 5, 745-751.
128. Spange, S., Wagner, T., Heinzel, T., and Kramer, O. H. (2009). Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int. J. Biochem. Cell. Biol. 41, 185-198.
129. Squatrito, M., Gorrini, C., and Amati, B. (2006). Tip60 in DNA damage response and growth control: Many tricks in one HAT. Trends Cell. Biol. 16, 433-442.
130. Stemmer, K., and Dietrich, D. (2008). Gender disparity in early ochratoxin A mediated renal toxicity. Toxicologist 102, 21.
131. Stemmer, K., Ellinger-Ziegelbauer, H., Ahr, H. J., and Dietrich, D. R. (2007). Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis. Cancer Res. 67, 4052-4068.
132. Stemmer, K., Ellinger-Ziegelbauer, H., Ahr, H. J., and Dietrich, D. R. (2009). Molecular characterization of preneoplastic lesions provides insight on the development of renal tumors. Am. J. Pathol. 175, 1686-1698.
133. Stetina, R., and Votava, M. (1986). Induction of DNA single-strand breaks and DNA synthesis inhibition by patulin, ochratoxin A, citrinin, and aflatoxin B1 in cell lines CHO and AWRF. Folia Biol. (Praha) 32, 128-144.
134. Steyn, P. S., Vleggaar, R., Du Preez, N. P., Blyth, A. A., and Seegers, J. C. (1975). The in vitro toxicity of analogs of ochratoxin A in monkey kidney epithelial cells. Toxicol. Appl. Pharmacol. 32, 198-203.
135. Storchova, Z., and Kuffer, C. (2008). The consequences of tetraploidy and aneuploidy. J. Cell. Sci. 121, 3859-3866.
136. Storchova, Z., and Pellman, D. (2004). From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell. Biol. 5, 45-54.
137. Stormer, F. C., Hansen, C. E., Pedersen, J. I., Hvistendahl, G., and Aasen, A. J. (1981). Formation of (4R)- and (4S)-4-hydroxyochratoxin A from ochratoxin A by liver microsomes from various species. Appl. Environ. Microbiol. 42, 1051-1056.
138. Sun, Y., Jiang, X., Chen, S., Fernandes, N., and Price, B. D. (2005). A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. U.S.A. 102, 13182-13187.
139. Sun, Z., Chin, Y. E., and Zhang, D. D. (2009). Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol. Cell. Biol. 29, 2658-2672.
140. Tang, Y., Luo, J., Zhang, W., and Gu, W. (2006). Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 24, 827-839.
141. Tsuda, M., Sekine, T., Takeda, M., Cha, S. H., Kanai, Y., Kimura, M., and Endou, H. (1999). Transport of ochratoxin A by renal multispecific organic anion transporter 1. J. Pharmacol. Exp. Ther. 289, 1301-1305.
142. Turesky, R. J. (2005). Perspective: Ochratoxin A is not a genotoxic carcinogen. Chem. Res. Toxicol. 18, 1082-1090.
143. Ueno, Y., Umemori, K., Niimi, E., Tanuma, S., Nagata, S., Sugamata, M., Ihara, T., Sekijima, M., Kawai, K., Ueno, I., et al. (1995). Induction of apoptosis by T-2 toxin and other natural toxins in HL-60 human promyelotic leukemia cells. Nat. Toxins 3, 129-137.
144. Vitale, I., Galluzzi, L., Senovilla, L., Criollo, A., Jemaa, M., Castedo, M., and Kroemer, G. (2011). Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ. 18, 1403-1413.
145. Wehner, F. C., Thiel, P. G., van Rensburg, S. J., and Demasius, I. P. (1978). Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins. Mutat. Res. 58, 193-203.
146. Wei, X., and Sulik, K. K. (1993). Pathogenesis of craniofacial and body wall malformations induced by ochratoxin A in mice. Am. J. Med. Genet. 47, 862-871.
147. Wurgler, F. E., Friederich, U., and Schlatter, J. (1991). Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102. Mutat. Res. 261, 209-216.
148. Xu, W., Edmondson, D. G., Evrard, Y. A., Wakamiya, M., Behringer, R. R., and Roth, S. Y. (2000). Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nat. Genet. 26, 229-232.
149. Zahoor Ul, H., Muhammad Zargham, K., Ahrar, K., Ijaz, J., and Mnaza, N. (2012). In vivo and ex vivo phagocytic potential of macrophages from progeny of breeder hens kept on ochratoxin A (OTA)-contaminated diet. J. Immunotoxicol 9, 64-71.
150. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelmans, K. (1988). Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ. Mol. Mutagen. 11(Suppl. 12), 1-158.
151. Zepnik, H., Pahler, A., Schauer, U., and Dekant, W. (2001). Ochratoxin A-induced tumor formation: Is there a role of reactive ochratoxin A metabolites? Toxicol. Sci. 59, 59-67.
152. Zepnik, H., Volkel, W., and Dekant, W. (2003). Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol. Appl. Pharmacol. 192, 36-44.
153. Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2011). Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004.
154. Zhivotovsky, B., and Kroemer, G. (2004). Apoptosis and genomic instability. Nat. Rev. Mol. Cell. Biol. 5, 752-762.
155. Zingerle, M., Silbernagl, S., and Gekle, M. (1997). Reabsorption of the nephrotoxin ochratoxin A along the rat nephron in vivo. J. Pharmacol. Exp. Ther. 280, 220-224.